Conversely, reduced frequencies of CD62L-expressing monocytes and CD86+ plasmacytoid DCs linked to lower osteomyelitis risk suggest that restrained antigen presentation capacity in these populations may mitigate inflammation. Here, CD86 is linked to osteomyelitis.